Looking to update your profile, access journals, or renew your membership? Log in to your My Account page.

Pediatric Rheumatology Symposium

Pediatric Rheumatology Symposium

In Person

Logo

About the Event

Date:March 18–21, 2026

Location:Minneapolis, MN

Credit:CME: TBA, ABIM & ABP MOC: TBA

On Demand:Not Available

The Pediatric Rheumatology Symposium (PRSYM) will provide up-to-date, practical clinical information and basic science knowledge on the diagnosis and management of pediatric patients with rheumatic diseases and immune disorders.

Key opinion leaders will deliver a range of content in areas such as therapeutic developments, recent research findings, and scientific advances, in an environment conducive to dialogue and networking.

Target Audience
Rheumatologists, physicians and other healthcare providers who care for pediatric patients with rheumatic diseases, clinical investigators, physician-scientists and those interested or engaged in research in the field of pediatric rheumatic diseases.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Discuss the most up-to-date clinical information on the diagnosis and management of pediatric patients with rheumatic and immunologic disorders
  • Describe the most current information regarding the pathophysiology underlying pediatric rheumatic disorders

See information from the 2023 meeting in the Pediatric Rheumatology Symposium 2023 section below.


Program Schedule & Syllabi

To Be Announced

Registered attendees can access the syllabi during the meeting and for 12 months after the meeting. To access syllabi, login and go to My Learning.


Registration Fees

Registration Coming Soon

Registration fees are available until 5:00 PM ET on the dates below.

Early Bird (ends November 13)
ACR Member: $737
ARP Member: $540
Fellow in training: $495
*Resident/student: $0
**Developing country: $0

Regular (after November 13)
ACR Member: $958
ARP Member: $702
Fellow in training: $643
*Resident/student: $0
**Developing country: $0

Guest Ticket (Closing Reception)
$150 (A guest ticket must be purchased together with another ticket type.)

*Fellow-in-Training, Resident, and Student Members
This category includes physicians enrolled in or who have completed a training program in rheumatology or a related field within the past year, individuals enrolled in a residency program who are interested in rheumatology as a subspecialty, students enrolled in a graduate-level educational program in medicine or a related field, or students enrolled in a health professional program leading to a baccalaureate or graduate degree. To be eligible for the reduced fee, members must provide a letter from your program director, chief of service, or faculty advisor.

**Member from Developing Countries
To be eligible for the reduced fee, members from countries with low-income and lower-middle-income economies, as determined by the World Bank, must provide evidence of work and residence address.

Registration fees are available until 5:00 PM ET on the dates below.

Early Bird (ends November 13)
Potential Member: $1,068.65
*Fellow in training: $836.55
**Developing country: $0

Regular (after November 13)
Potential Member: $1,389.25
*Fellow in training: $1,087.52
**Developing country: $0

Guest Ticket (Closing Reception)
$150 (A guest ticket must be purchased together with another ticket type.)

*Potential Fellow-in-Training, Resident, and Student Members
This category includes physicians enrolled in or who have completed a training program in rheumatology or a related field within the past year, individuals enrolled in a residency program who are interested in rheumatology as a subspecialty, students enrolled in a graduate-level educational program in medicine or a related field, or students enrolled in a health professional program leading to a baccalaureate or graduate degree. To be eligible for the reduced fee, potential members must provide a letter from your program director, chief of service, or faculty advisor.

**Potential Member from Developing Countries
To be eligible for the reduced fee, potential members from countries with low-income and lower-middle-income economies, as determined by the World Bank, must provide evidence of work and residence address.

Registration Guidelines

Full payment is due at the time of registration.

Cancellations and Refund Requests

  • All registrations are final and non-refundable. Please submit any issues in writing to education@rheumatology.org and they will be evaluated on a case-by-case basis. If a refund is granted, an administrative fee will be deducted: $100 for members and $150 for non-members.
  • No-shows will not receive a refund.
  • ACR is not responsible for airfare, hotel, or other costs incurred by participants in the event of a program or registration cancellation, or delays or cancellations due to inclement weather.
  • Cancelled registrations are nontransferable.

If you have any questions, please email education@rheumatology.org.


Hotel

The meeting will be held at the Hyatt Regency Minneapolis. Rooms are on a first-come, first-served basis.

Hyatt Regency Minneapolis
1300 Nicollet Mall
Minneapolis, MN 55403
Phone: 612-370-1234
Book Hotel Online

Nightly Rates
Single/Double Occupancy Rate: $195

Room rates are subject to city/state taxes. The Guest Room Rates are quoted exclusive of any applicable taxes (which are currently 15.025%), applicable service fees, and/or Hotel-specific fees in effect at the time of the Event. Currently, a Downtown Improvement District Recovery Fee will also be added, at $2.00 per night, subject to change.

After February 18, room rates cannot be guaranteed. Check with the hotel for any early departure fees and cancellation/refund policies.


Travel

Minneapolis–Saint Paul International Airport (MSP)
12 miles/25 minutes from Hyatt Regency Minneapolis

Ground Transportation Airport Directions
Uber: $40–$55
Taxi: $39–$49
Metro Options

Prices are subject to change.


Press Registration

The American College of Rheumatology welcomes members of the press to write about research presented at our meetings. Complimentary registration is provided to approved members of the press to allow them to attend sessions on site.


Acknowledgement of Commercial Support

No commercial support was provided for this activity.

Exhibits and Sponsorships
Support this educational event by becoming an exhibitor or sponsor. Contact Kat Dennis (kdennis@rheumatology.org) with questions or to secure your spot.

CME

ACCME Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

See the ACR’s CME Mission Statement. For more information, download the AMA PRA Booklet.

AMA Designation Statement
The ACR designates this Live Activity for a maximum of (to be announced) AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME credit must be claimed by May 20, 2026, at 11:59 PM ET.

MOC

MOC Recognition Statement: American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to (to be announced) MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board.

After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.

ABIM CME/ MOC accredited

 

MOC Recognition Statement: American Board of Pediatrics (ABP)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to (to be announced) MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABP diplomates to the ABP diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABP Physician Portals. Please allow at least 48 hours for points to display in the portal.

MOC points must be claimed by May 20, 2026, at 11:59 PM ET.

ABP MOC

Instructions to Claim CE/MOC Credit

Credit claiming is available after the activity starts.

See instructions to claim credit on the CME & MOC page.

ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.

Nature of Financial Relationships
All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:

  1. Advisor or review panel member
  2. Consultant
  3. Employee
  4. Officer or Board Member
  5. Grant/research support
  6. Speaker/honoraria includes speakers bureau, symposia, and expert witness
  7. Independent contractor
  8. Executive role and/or ownership interest
  9. Royalties and/or patient beneficiary
  10. Intellectual property/patents
  11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan
  12. Private investigator
  13. Expert witness
  14. Equity interest
  15. Other: specify details

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.

2026 disclosures to be announced.

View ACR's ACCME disclosure practices

See 2023 disclosures in the 2023 meeting section below.

See key takeaways from your colleagues that attended PRSYM 2023.

Attendee Welcome Packet

CME & MOC Information

CME: 20.75
ABIM & ABP MOC: 20.75

CME credit must be claimed by March 30, 2024 at 11:59 PM ET.

MOC points must be claimed by December 31, 2023 at 11:59 PM ET.

Target Audience
Rheumatologists, physicians and other healthcare providers who care for pediatric patients with rheumatic diseases, clinical investigators, physician-scientists and those interested or engaged in research in the field of pediatric rheumatic diseases.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Discuss the most up-to-date clinical information on the diagnosis and management of pediatric patients with rheumatic and immunologic disorders
  • Describe the most current information regarding the pathophysiology underlying pediatric rheumatic disorders

Program Schedule & Syllabi

Pediatric Rheumatology Symposium Program Schedule

Registered attendees can access the syllabi during the meeting and for 12 months after the meeting. To access syllabi, login and go to My Learning.


On-Demand

On-demand access for this activity is no longer available.


Financial Relationships Disclosures

ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.

Nature of Financial Relationships
All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:

  1. Advisor or review panel member
  2. Consultant
  3. Employee
  4. Officer or Board Member
  5. Grant/research support
  6. Speaker/honoraria includes speakers bureau, symposia, and expert witness
  7. Independent contractor
  8. Executive role and/or ownership interest
  9. Royalties and/or patient beneficiary
  10. Intellectual property/patents
  11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan
  12. Private investigator
  13. Expert witness
  14. Equity interest
  15. Other: specify details

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.

See PRSYM 2023 Disclosures


Abstracts

Accepted Pediatric Rheumatology Symposium 2023 abstracts are available on the ACR abstracts website.


Acknowledgement of Commercial Support

No commercial support was provided for this activity.

We use cookies on our website to improve our service to you and for security purposes. By continuing to use our site without changing your browser cookie settings, you agree to our cookie policy and the use of cookies. See ACR Policies